Trade Summary
5 days ago, Ridloff Elena, serving as Dir at Kymera Therapeutics, Inc. (KYMR), sold 12,000 shares at $85.39 per share, for a total transaction value of $1,024,660.00.
This sale represents a 100.00% decrease in Ridloff Elena's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Tuesday, March 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 1, 2026, 1 day after the trade was made.
Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.